1
Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:February 14, 2023Completed
Etripamil as an Intervention: 9 Clinical Trials
Hide Studies Not Open or Pending
2
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:March 10, 2023Not yet recruiting
3
A Study of Etripamil in Healthy Subjects
Condition(s):Healthy Chinese SubjectsLast Updated:April 10, 2023Completed
4
ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2
Condition(s):Atrial FibrillationLast Updated:February 24, 2023Recruiting
5
Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:March 15, 2023Enrolling by invitation
6
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Condition(s):Tachycardia, Supraventricular; Paroxysmal Supraventricular TachycardiaLast Updated:August 17, 2022Recruiting
7
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:April 24, 2023Terminated
8
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]
Condition(s):Paroxysmal Supraventricular TachycardiaLast Updated:February 14, 2023Completed
9
Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
Condition(s):Paroxysmal Supraventricular Tachycardia (PSVT)Last Updated:December 30, 2020Completed